registHER: A prospective, longitudinal cohort study of women with HER2 positive metastatic breast cancer.

被引：0
|
作者：
Tanchiu, E
Kaufman, PA
Paik, S
Ulcickas-Yood, M
Mayer, M
Tripathy, D
Rugo, H
Brufsky, A
机构：
[1] Canc Res Network, Plantation, FL USA
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[3] NSABP, Pittsburgh, PA USA
[4] Episource LLC, Hamden, CT USA
[5] Patient Advocate, New York, NY USA
[6] Univ Texas, SW Med Ctr, Dallas, TX 75230 USA
[7] Univ Calif San Francisco, San Francisco, CA 94143 USA
[8] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：46S / 46S
页数：1
相关论文
共 50 条
  • [1] registHER: Results from a prospective, longitudinal cohort study of women with HER2 positive metastatic breast cancer.
    Rugo, HS
    Yardley, D
    Tan-Chiu, E
    Brufsky, A
    Kaufman, P
    Paik, S
    Ulcickas-Yood, M
    Mayer, M
    Tripathy, D
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S90 - S90
  • [2] registHER: treatments and clinical outcomes from a prospective observational cohort study of patients with HER2-positive metastatic breast cancer.
    Brufsky, A
    Rugo, H
    Tripathy, D
    Kaufman, P
    Mayer, M
    Paik, S
    Ulcickas-Yood, M
    Yardley, D
    Tan-Chiu, E
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S148 - S148
  • [3] registHER: An observational cohort study of patients with HER2+metastatic breast cancer
    Yood, Marianne Ulcickas
    Kaufman, Peter A.
    Mayer, Musa
    Rugo, Hope
    Brufsky, Adam
    Tan-Chiu, Elizabeth
    Yardley, Denise
    Paik, Soonmyung
    Wang, Lisa
    Birkner, Merrill
    Brammer, Melissa
    Tripathy, Debu
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S40 - S40
  • [4] Prospective Validation and Characterization of HER2 Positive Circulating Tumor Cells in Patients with HER2 Negative Metastatic Breast Cancer.
    Olson, E. M.
    Flores, L. M.
    Najita, J. S.
    Curley, C.
    Jeong, J.
    Murray, K.
    Savoie, J. J.
    Winer, E. P.
    Krop, I. E.
    [J]. CANCER RESEARCH, 2011, 71
  • [5] HER2 overexpressing metastatic breast cancer.
    Spigel D.R.
    Burstein H.J.
    [J]. Current Treatment Options in Oncology, 2002, 3 (2) : 163 - 174
  • [6] Tolerability of neratinib in older adults with HER2 positive or HER2 mutated metastatic breast cancer.
    Lee, Jin Sun
    Yost, Susan Elaine
    Stiller, Tracey
    Blanchard, Suzette
    Padam, Simran
    Katheria, Vani
    Tang, Aileen
    Martinez, Norma
    Patel, Niki Himat
    Sedrak, Mina S.
    Waisman, James Ross
    Li, Daneng
    Sanani, Shamel
    Presant, Cary A.
    Mortimer, Joanne E.
    Yuan, Yuan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Prognostic nomogram for patients with non-metastatic HER2 positive breast cancer in a prospective cohort
    Luo, Chuanxu
    Zhong, Xiaorong
    Wang, Zhu
    Wang, Yu
    Wang, Yanping
    He, Ping
    Peng, Qian
    Zheng, Hong
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2019, 34 (01): : 41 - 46
  • [8] Trastuzumab and vinorelbine combination in the treatment of Her2 positive metastatic breast cancer.
    Bayo, J
    Mayordomo, JI
    Sanchez-Rovira, P
    Perez-Carrion, R
    Illaramendi, J
    Flores, EG
    Bueno, JMG
    Vazquez, MR
    Crespo, C
    Palomo, AG
    Huelva, HJRJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 67S - 67S
  • [9] registHER: patient characteristics and time course of CNS metastases in patients with HER2-positive metastatic breast cancer.
    Yardley, D. A.
    Kaufman, P. A.
    Mayer, M.
    Ulcickas, Yood M.
    Tan-Chiu, E.
    Brufsky, A. M.
    Rugo, H. S.
    Tripathy, D.
    Brammer, M. G.
    Paik, S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S263 - S264
  • [10] Prognostic role of plasma HER2 gene copy number in patients with HER2 positive metastatic breast cancer.
    Ran, Ran
    Huang, Wenfa
    Lin, Shao
    Niu, Yunyun
    Rugo, Hope S.
    Kong, Weiyao
    Bo, Shiping
    Lu, Sijia
    Li, Huiping
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345